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The positive charge of cationic-lipid/DNA complexes (lipoplexes) renders them highly susceptible to interactions with the biological
milieu, leading to aggregation and destabilization, and rapid clearance from the blood circulation. In this study we synthesized and
characterized a set of novel amphiphiles, based on N-methyl-4-alkylpyridinium chlorides (SAINTs), to which a PEG moiety is coupled.
Plasmids were fully protected in lipoplexes prepared from cationic SAINT-2 lipid and stabilized with SAINT-PEGs. Our results demonstrate
that SAINT-PEG stabilization is transient, and permits DNA to be released from these lipoplexes. The rate of SAINT-PEG transfer from
lipoplexes to acceptor liposomes was determined by the nature of the lipid anchor. Increased hydrophobicity, by lengthening the alkyl chain,
resulted in a decrease of the rate of DNA release from the lipoplexes. Chain unsaturation had the opposite effect. Similarly, the in vitro
transfection potency of lipoplexes containing PEG-SAINT derivatives was sensitive to the length and (un)saturation of the alkyl chain.
However, the internalization of SAINT-PEG stabilized lipoplexes is determined by their charge, rather than by the concentration of the
polymer conjugate. Lipoplexes targeted to cell-surface epithelial glycoprotein 2, by means of a covalently coupled monoclonal antibody,
were specifically internalized by cells expressing this antigen.
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In recent years it has become apparent that synthetic
amphiphiles provide a promising novel tool in the develop-
ment of gene carrier systems. Introduction of nucleic acids
into cells using cationic lipids results in efficient cellular
transfection that is usually far superior over that accom-
plished via other non-viral systems. Moreover, synthetic
amphiphiles are readily susceptible to chemical modifica-
tions, conveying specific properties to these molecules as
such or providing possibilities for coupling with specific
molecules.0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2003.10.011
Abbreviations: Cer, ceramides; DODAC, dioleyldimethylammonium
chloride; DOPE, dioleoylphosphatidylethanolamine; DOPC, dioleoylphos-
phatidylcholine; DOPS, dioleoylphosphatidylserine; EGP-2, epithelial
glycoprotein 2; GFP, green fluorescent protein; HBSS, Hank’s balanced
salt solution; PEG, polyethylene glycol; SAINT, N-methyl-4-alkylpyridium
chloride; SATA, (N-succinimidyl-S-acetylthioacetate)
* Corresponding author. Tel.: +31-50-363-2741; fax: +31-50-363-27-
28.
E-mail address: d.hoekstra@med.rug.nl (D. Hoekstra).However, the use of lipid-based carrier systems in vivo
calls for some additional requirements to be fulfilled. For
example, positively charged particles are especially prone to
undesired interactions with plasma proteins, which can lead
to destabilization and rapid clearance of the lipoplexes by
macrophages before they reach the diseased tissue. Numer-
ous approaches based on surface modifications have been
proposed to decrease particle interactions with biological
components resulting in increased blood circulation times.
Currently the synthetic polymer polyethylene glycol (PEG),
which can be easily synthesized in large amounts at high
purity is the preferred substance to achieve this effect. The
most beneficial characteristics of PEG are: chemical inert-
ness, nonionic character, high water solubility and low cost
[1,2].
The PEG moiety can be conjugated to phosphatidyle-
thanolamines such as DSPE, serving as a bilayer anchor, via
a carbamate linkage. However, it has been speculated that
the net negative charge on the phosphate moiety may have
undesirable effects on particle pharmacokinetics [3]. Fur-
thermore, recent studies, in which the DSPE-PEG conjugate
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that the use of DSPE as a firm anchor brings along other
drawbacks. It has been demonstrated that such a stable
steric barrier strongly inhibits nucleic acid release from the
endosomal compartment, precluding its delivery to the
nucleus. Interestingly, the cell association and subsequent
endocytosis of these lipoplexes were not altered by PEG
[4–6]. Exchangeable PEG-derivatives, stabilizing a particle
in a time-dependent manner, may circumvent these prob-
lems, as illustrated by the use of PEG-ceramides. It has
been shown that the rate of PEG-ceramide release from the
particle depends on the size of the PEG moiety as well as on
the acyl chain length [7,8]. In biological membranes,
ceramide-based lipids readily engage in H-bonding-driven
interactions, an instrumental property in formation of sphin-
golipid-enriched domains, also known as ‘rafts’. Whether
such self-aggregating properties also affect their lateral
behavior in cationic lipid complexes remains unknown,
but such features may affect the controlled dissociation
from lipoplexes. Taking also into account economical con-
siderations for in vivo application, we therefore set out to
develop novel exchangeable PEG-derivatives, which should
closely resemble the lipophilic structure of the amphiphile
in the lipoplex and whose synthesis should be relatively
simple. To this end, we synthesized cationic lipids with a
conjugated PEG moiety, relying on our previous studies in
which we employed N-methyl-4-alkylpyridinium chlorides,
a class of cationic lipids abbreviated as SAINT [9–11].
Their properties were characterized in terms of their ex-
changeability and potential for regulated and controlled
gene delivery.2. Materials and methods
2.1. Materials
The cationic lipid SAINT-2 was synthesized as described
elsewhere [12]. DSPE-PEG2000, DOPE, DOPS, and DOPC
were obtained from Avanti Polar Lipids (Alabaster, AL,Fig. 1. Schematic representation of the synthesis of polyethylene glycol-coupled
chains as indicated in a–e, to which PEG (Mw 2000 kDa (n= 45)) was coupled.USA). PEG-ceramides were from Northern Lipids (Vancou-
ver, Canada). Polyethylene glycol monomethyl ether with
molecular weight of 2000 was purchased from Fluka, and
dried in vacuum above P2O5 before use. 2,4,4,6-Tetrabromo-
2,5-cycloheadien-1-one (95%) was from Acros. All other
chemicals were from Sigma, unless indicated otherwise.
2.2. Cell culture
Murine melanoma B16.F10 cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented
with 10% FCS and 100 Ag/ml penicillin/streptomycin
(Gibco BRL, Life Technology, Merelbeke, Begium) at
37 jC (5% CO2). EGP-2 expressing B16 melanoma cells
(B16.C215) were cultured under the same conditions, but in
the presence of 500 Ag/ml G 418.
2.3. Transfection
B16 cells were plated 1 day prior to transfection in 6- or
12-well plates. The cells were incubated with the lipoplexes
in FCS-supplemented cell culture medium (10%) for 4 h at
37 jC (50 Al of lipoplexes + 450 Al of medium—6-well
plates; 100 Al of lipoplexes + 900 Al of medium—12-well
plates). Then the cells were washed and treated with serum-
containing medium, which was refreshed after 24 h of
culture. Three days after transfection (unless indicated
otherwise), the cells were washed with HBSS and examined
by fluorescence-activated cell sorting (FACS). Note that the
transfection capacity of the cationic lipid formulations
employed in the present study was not significantly affected
by the presence of serum, as previously reported [5,10].
2.4. Synthesis of SAINT-PEG derivatives
The overall synthetic pathway is illustrated in Fig. 1.
Individual compounds were synthesized, purified and char-
acterized as described in detail in the following subsections.
1H-NMR and 13C-NMR spectra were run on a Varian
Gemini 200 or Varian VXR 300 spectrometer.SAINT derivatives. The PEG-SAINTS consisted of SAINTs with dialkyl
For details see Section 2.
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Triphenylphosphine (1.180 g; 4.5 mmol) was dissolved
in 13 ml of dry dichloromethane. 2,4,4,6-Tetrabromo-2,5-
cyclohexadien-1-one (1.843 g; 4.5 mmol) was added. The
mixture was stirred for 2 h. After salt formation was
completed (checked with 31P-NMR, solvent C6D6), 2.87-g
polyethylene glycol monomethyl ether (2000) was added.
Stirring was continued for 5 days. The solvent was removed
by evaporation in vacuum and the residue was treated with
25-ml distilled water. The aqueous solution was filtered and
centrifuged for 1 h. The clear solution was decanted and
freeze-dried; yield: 2.576 g of a white powder (90%). If
necessary, traces of triphenylphosphorousoxide can be re-
moved by dispersing a dichloromethane solution of the
compound in an excess of ether followed by filtration
by suction and drying. 13C-NMR (75.4 MHz, CDCl3):
d = 30.15, 58.83, 70.33, 70.99, 71.71 [15].
2.5. SAINT-PEG synthesis
To a solution of 0.2 g (0.1 mmol) Br-PEG2000-OCH3 in
absolute ethanol was added the corresponding pyridine in a
10-fold excess. The solution was refluxed for 7–14 days.
The reaction was followed by 1H-NMR. The solvent was
removed and the residue was purified by chromatography
on Al2O3 (neutral, activity III), gradient elution with a
mixture of dichloromethane/2–10% methanol, and crystal-
lization from acetone/ether (1:1) gave the products in 60–
80% yield.
2.5.1. 4-(Didodecylmethyl)-1-(PEG2000OCH3)-pyridinium
bromide (a)
Crystallization from acetone/ether gave white crystals,
mp 42–45 jC. 1H-NMR (300 MHz, CDCl3): d = 0.85 (t,
6 H), 1.22 (m, 40 H), 1.54 (m, 2 H), 1.71 (m, 2 H), 2.74 (m,
1 H), 3.35 (s, 3 H), 3.62 (m, PEGchain), 4.05 (m, 2 H), 5.17
(m, 2 H), 7.66 (d, J = 6.6 2 H), 9.50 (d, J = 6.6 2 H). 13C-
NMR (50.3 MHz, CDCl3): d = 13.89, 22.44, 27.21, 29.10,
29.16, 29.38, 31.66, 35.45, 46.34, 58.78, 60.09, 69.39,
69.92, 70.11, 70.28, 71.66, 126.34, 145.06, 166.89.
2.5.2. 4-(Ditetradecylmethyl)-1-(PEG2000OCH3)-pyridi-
nium bromide (b)
White crystals mp 45–46 jC. 1H-NMR (300 MHz,
CDCl3): d = 0.87 (t, 6 H), 1.24 (m, 48 H), 1.57 (m, 2 H),
1.73 (m, 2 H), 2.76 (m, 1 H), 3.37 s, 3 H), 3.64
(m, PEGchain), 4.08 (m, 2 H), 7.68 (d, J= 6.6 2 H), 9.51
(d, J = 6.6 2 H). 13C-NMR (50.3 MHz, CDCl3): d= 14.00,
22.55, 27.30, 29.27, 29.51, 31.77, 35.57, 46.46, 60.09,
70.39, 71.77, 126.40, 145.14, 167.07.
2.5.3. 4-(Dihexadecylmethyl)-1-(PEG2000OCH3)-pyridi-
nium bromide (c)
White crystals mp 46–47 jC. 1H-NMR (300 MHz,
CDCl3): d = 0.81 (t, 6 H), 1.18 (m, 56 H), 1.50 (m, 2 H),
1.66 (m, 2 H), 2.70 (m, 1 H), 3.32 (s, 3 H), 3.58
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J = 6.2 2 H) 9.46 (d, J = 6.2 2 H). 13C-NMR (50.3 MHz,
CDCl3), d = 13.92, 22.46, 27.21, 29.13, 29.18, 29.30, 29.46,
31.68, 35.48, 46.35, 58.80, 60.03, 69.47, 69.94, 70.32,
71.69, 126.30, 145.10, 166.89.
2.5.4. 4-(Dioctadecylmethyl)-1-(PEG2000OCH3)-pyridinium
bromide (d)
White crystals mp 47–48 jC. 1H-NMR (300 MHz,
CDCl3): d = 0.84 (t, 6 H), 1.21 (m, 64 H), 1.54)m, 2 H),
1.68 (m, 2 H), 2.73 (m, 1 H), 3.35 (s, 3 H), 3.61
(m, PEGchain), 4.06 (m, 2 H), 5.16 (m, 2 H) 7.66 (d,
J = 6.2 2 H), 9.49 (d, J = 6.2 2 H). 13C-NMR (50.3 MHz,
CDCl3): d = 13.99, 22.55, 27.31, 29.22, 29.27, 29.39, 29.56,
31.77, 35.57, 46.47, 58.90, 60.04, 69.56, 70.02, 70.38,
71.77, 126.38, 145.38, 167.05.
2.5.5. 4-(Dioleylmethyl)-1-(PEG2000OCH3)-pyridinium
bromide (e)
White crystals mp 44–45 jC. 1H-NMR (300 MHz,
CDCl3): d = 0.85 (t, 6 H), 1.23 (m, 52 H), 1.55 (m, 2 H),
1.71 (m, 2 H), 1.96 (m, 8 H), 2.74 (m, 1 H), 3.35 (s, 3 H),
3.61 (m, PEGchain), 4.06 (m, 2 H), 5.16 (m, 2 H), 5.31
(m, 4 H), 7.66 (d, J = 5.9 2 H), 9.47 (d, J= 5.9, 2 H). 13C-
NMR (50.3 MHz, CDCl3): d = 13.90, 22.44, 26.95, 27.21,
28.99, 29.06, 29.13, 29.26, 29.50, 31.65, 35.46, 46.36,
58.79, 60.02, 69.43, 69.94, 70.30, 71.68, 126.28, 129.48,
129.72, 145.05, 166.88.
2.6. Liposome and lipoplex preparation
Liposomes were formed by mixing lipids in a chloro-
form/methanol solution and drying under a stream of
nitrogen gas. The remnants of solvents were removed by
additional drying in vacuum for 2 h. The lipid film was
subsequently re-suspended in deionized water by intense
vortexing, resulting in the formation of multilamellar
vesicles (MLVs). This suspension was sonicated in a bath-
type sonicator until clarity. Vesicles were composed of
SAINT-2/DOPE (50:50, mole ratio); SAINT-2/DOPE/
PEG- l i p i d ( 4 5 : 4 5 : 1 0 ) , SA INT- 2 /DOPE /RhPE
(49 .5 :49 .5 :1 ) ; SAINT-2 /DOPE/PEG- l ip id /RhPE
(45:45:10:1), unless indicated otherwise.
To visualize and quantify internalized lipoplexes, 1% of
N-Rh-PE was added to the lipids prior to drying. To
distinguish between cell-bound and internalized lipoplexes,
cells were treated with a quencher (trypan blue) and ana-
lyzed by FACS or confocal microscopy.
Lipoplexes were prepared at a SAINT to DNA molar
charge ratio 2.5:1, unless indicated differently: 0.5 ml of
medium containing 1 Ag/ml of pDNA (pEGFP-N1, Clo-
netech) was added to 0.5 ml of medium containing a
solution of cationic liposomes. The average size of the
lipoplexes employed in this work ranged from 200 to
250 nm as determined by dynamic light scattering (not
shown).
Bioph2.7. Plasmid preparation
The plasmid (pEGFP-N1; Clontech, Palo Alto, USA)
was isolated form Escherichia coli with the Maxi-Prep Kit
from Qiagen (Hilden, Germany). Isolated DNA was stored
in TE buffer (100mM NaCl, 10 mM Tris–HCl) at a
concentration of 1 mg/ml after verifying its purity by
determining the ratio of absorbance at 260/280 nm and by
gel electrophoresis.
2.8. Agarose gel electrophoresis of lipoplexes
Lipoplexes were prepared with plasmid DNA and
SAINT-2/DOPE or SAINT-2/DOPE/PEG-lipid vesicles,
as described above. The lipoplexes were incubated with
100 units of DNase I for 30 min at 37 jC in the
presence of MgCl2. 1% Zwittergent (Calbiochem, La
Jolla, CA, USA) was used to release DNA from the
lipoplexes. Samples in glycerol were loaded on a 0.8%
agarose gel containing 1.25 AM EtBr immersed in TBE
buffer.
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prepared and the plasmids accessibility was determined by an incubation in the pre
was then analyzed by agarose chromatography, and quantified (indicated as Ban
Corporation. Treatments of each sample were as indicated at the top of each lane, a
14—samples were treated with detergent alone (1% Zwittergent); Lanes 3, 7, 11, 1
16—samples treated with a detergent followed by DNase I digestion. (B) Lipopl
plasmid accessibility by an incubation with DNase I, as in (A). Conditions were as
were treated with detergent alone (1% Zwittergent); Lanes 3, 7—samples were inc
treated with 1% Zwittergent, followed by DNase I.2.9. Monitoring of DNA accessibility by a picogreen assay
Lipoplexes were added to a picogreen solution (Molec-
ular Probes, Eugene, OR, USA) prepared according to the
manufacturer’s protocol. The amount of DNA accessible for
labeling was measured with a fluorometer (Perkin Elmer LS
55, kex 502 nm, kem 520 nm). Triton X-100 was added to
determine the amount of total DNA present in each sample.
2.10. Anionic vesicle-induced release of DNA from
lipoplexes
Lipoplexes prepared in HBSS were added to a picogreen
solution, prepared according to the manufacturer’s instruc-
tions, followed by addition of PS/PE/PC (1:2:1) liposomes
in a fivefold molar excess. The change in fluorescence,
indicating an increase in the amount of accessible DNA, was
subsequently measured online with a fluorometer (Perkin
Elmer LS55, kex 502 nm, kem 520 nm). The value of total
DNA present was determined by the addition of Triton X-
100 solution at the end of each measurement.
ysica Acta 1660 (2004) 41–52. (A) C14:0 and C12:0 SAINT-PEG (10 mol%) containing lipoplexes were
sence of DNase, as described in Section 2. The extent of DNA degradation
d 1 intensity) by using ScionImage computer software provided by Scion
s follows: Lanes 1, 5, 9, 13—samples without any treatment; Lanes 2, 6, 10,
5—samples exposed to DNase I (100 units, 30 min, 37 jC); Lanes 4, 8, 12,
exes, containing DSPE-PEG or PEG-Cer20 (10 mol%), were analyzed for
follows: Lanes 1, 5—samples without any treatment; Lanes 2, 6—samples
ubated with DNase I (100 units, 30 min, 37 jC); Lanes 4, 8—samples were
Biophysica Acta 1660 (2004) 41–52 452.11. FACS analysis
FACS analysis was performed on a Coulter Elite flow
cytometer. The cells were screened for the reporter gene 3
days after transfection, unless indicated differently. Cells
were washed three times with HBSS, trypsinized, centri-
fuged and resuspended in HBSS. 5000–10000 cells were
measured in each sample (kex 488, kem 530).
2.12. Coupling of antibody
The MOC-31 antibody was coupled to MPB-containing
lipoplexes by a sulfhydrylmaleimide coupling method de-
scribed previously [16]. Briefly, SATA (N-succinimidyl l-S-
acetylthioacetate) was used to introduce free sulfhydryl
groups in the antibody. Free SATA was separated by gel
permeation chromatography using Sephadex G-50. MPB-
containing lipoplexes were incubated with antibody con-
taining reactive sulfhydryl groups for 4 h at room temper-
ature (0.3 mg antibody/Amol of lipid). Unreacted sulfhydryl
groups were capped by N-ethylmaleimide (8 mM). Uncon-
jugated antibody was separated from lipoplexes by flotation
on a metrizamide gradient as described elsewhere [17].
Subsequently, lipoplexes were dialyzed against HN-buffer,
pH 7.4. The average amount of antibody coupled to lip-
oplexes was 30 Ag/Amol lipid.
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PEGylated lipoplexes. Lipoplexes were added to a picogreen solution,
followed by the addition of PS/PE/PC (1:2:1) liposomes in fivefold molar
excess. The changes in fluorescence, indicating an increase in the amount of
accessible DNA, were measured with a fluorometer. The value of total
DNA accessibility was determined by the addition of a Triton X-100
solution (1%, final concentration) at the end of each measurement. (A)
Fluorescence development obtained for lipoplexes consisting of SAINT-2/
DOPE (50:50). (B) Lipoplexes were prepared with various PEGylated
derivatives (10 mol%) as follows: SAINT-2/DOPE/SAINT12:0-PEG (1),
SAINT-2/DOPE/SAINT16:0-PEG (2) and SAINT-2/DOPE/DSPE-PEG (3).
Anionic lipid vesicles were added after 300 s. (C) SAINT-2/DOPE/
SAINT12:0-PEG; PEG content: 0 (1), 0.5 (2), 1 (3) or 2 (4) mol%. Anionic
vesicles were added after 450 s. Note that the presence of PEG inhibits
DNA release from lipoplexes induced by the addition of anionic vesicles
(A vs. B), and that release of DNA requires reduction in PEG content to 1
mol% or less (C).3. Results
3.1. Plasmid DNA in lipoplexes coated with SAINT-PEGs is
effectively protected
To verify the relative extent to which SAINT-PEGs
potentially perturbed the lipoplex structure and hence
caused undesirable plasmid exposure, lipoplexes containing
either SAINT-PEGs, ceramide-PEG and DSPE-PEG were
examined for DNase I sensitivity.
Samples containing 1 Ag DNA (pEGFP-N1) complexed
with SAINT-2/DOPE or SAINT2/DOPE/lipid-PEG were
exposed to 100 units of DNase I for 30 min at 37 jC. As
shown in Fig. 2A, plasmid complexed with SAINT-2/DOPE
(50:50) is insensitive to DNase I activity (compare lane 6 vs.
lane 7). Essentially identical results were obtained for
complexes containing SAINT-PEGs. Examples are pre-
sented in lanes 9–16 for the C12:0 and C14:0 derivatives.
These data were confirmed when plasmid DNA accessibility
was assayed for labeling with picogreen. Both in control and
SAINT-PEG-containing samples, the degree of labeling
amounted approximately 20% (not shown). By contrast, as
shown in Fig. 2B and reflected by the picogreen assay,
inclusion of C20:0 ceramide-PEG or PEG-DSPE almost
doubled the plasmids accessibility, showing an enhanced
degradation (compare band I intensities in Fig. 2B) and
degree of picogreen labeling (40–50%; not shown). Thus,
relative to DSPE-PEG and Cer-PEG, the SAINT-PEG
Fig. 4. Time-dependent transfer properties of SAINT-PEGs. Lipoplexes
were incubated with POPC liposomes (25-fold excess) for different periods
of time. Subsequently, they were transferred into a picogreen solution
followed by addition of PS/PE/PC (1:2:1) liposomes in a fivefold molar
excess. The changes in DNA accessibility for labeling with picogreen were
measured with a fluorometer. The 100% value reflects the fluorescence
intensity obtained after addition of Triton X-100 (1%, final concentration) to
non-PEGylated lipoplexes. Lipoplexes employed were as follows: SAINT-2/
DOPE/SAINT12:0-PEG (5); SAINT-2/DOPE/SAINT14:0-PEG (n); SAINT-
2/DOPE/SAINT18:1-PEG (o). The PEG–lipid concentration was 5 mol%.
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SAINT lipoplexes.
3.2. SAINT-PEG lipids stabilize lipoplexes by precluding
membrane–membrane interactions
According to the model proposed by Xu and Szoka [18]
and further extended by Hafez et al. [19] as well as based
upon the experimental data obtained by other groups [4–6],Fig. 5. Time-dependent transfection of B16 cells mediated by SAINT-2/DOPE li
day prior to transfection. The cells were incubated with the lipoplexes for 4 h a
containing medium, which was refreshed after 24 h of culture. The cells were wa
Lipoplexes used were: SAINT-2/DOPE/SAINT12:0-PEG (SAINT-2/DOPE (1:1);
PEG 10 mol%).it became evident that a close contact between endosomal
membrane and lipoplex is required for nucleic acid release
and subsequent transfection. Thus, steric stabilization of
lipoplexes has to be transient for efficient transfection to
occur, implying that SAINT-PEG derivatives should disso-
ciate from lipoplexes in a time-dependent manner. To
mimic the endosomal escape of DNA, the interaction of
PEGylated lipoplexes with anionic vesicles was investigat-
ed by recording changes in the amount of nucleic acid
accessible for the fluorescent dye picogreen. As shown in
Fig. 3A, the addition of anionic vesicles to SAINT-2/DOPE
lipoplexes results in an abrupt enhancement of the pool of
plasmid DNA, which becomes accessible to the dye. This is
due to both release of the DNA from the complex as a
result of electrostatic competition of the anionic lipid and
DNA for association with the cationic amphiphile, and
destabilization of the complex following anionic lipid-
induced non-lamellar transitions upon mixing with the
cationic lipids [5,20]. The presence of the PEG coating
effectively inhibited this process, as demonstrated for
SAINT-PEGs (Fig. 3B) and DSPE-PEG (Fig. 3B). Interest-
ingly, the C5:0 SAINT-PEG derivative did not show any
inhibitory effect (data not shown), and the kinetics of
picogreen fluorescence development was identical to that
shown in Fig. 3A.
These data emphasize the need for dissociation of the
PEGylated lipid derivative in order to destabilize the
lipoplex structure, necessary for plasmid release, which
requires a direct interaction between lipoplex and target
membrane. As shown in Fig. 3C, concentrations as low as
2 mol% SAINT-PEG effectively shield the lipoplexes
from interaction with anionic lipid vesicles, as reflected
by the poor picogreen fluorescence development at such
conditions.poplexes, stabilized with SAINT-PEG derivatives. B16 cells were plated 1
t 37jC. After this period, the cells were washed and treated with serum-
shed with HBSS and examined by FACS, 1, 2 or 3 days after transfection.
PEG 10 mol%); SAINT-2/DOPE/SAINT16:0-PEG (SAINT-2/DOPE (1:1);
Biophysica Acta 1660 (2004) 41–52 473.3. Alkyl chain length and (un)saturation govern dissoci-
ation of SAINT-PEG conjugates from lipoplexes
The foregoing results imply that the PEG shield requires
an almost complete disappearance in order to allow a direct
interaction between lipoplex and target membrane. There-
fore, we assumed that the time needed for DNA to become
accessible to picogreen labeling, following addition of
anionic lipid vesicles and in the presence of an appropriate
acceptor for the PEGylated lipids, could be taken as an
indirect measure of the PEG–lipid exchange rate. POPC
liposomes, which were included in the incubation mixture,
were utilized as acceptor vesicles for SAINT-PEGs. In this
set of experiments, the initial molar ratio of PEG–lipids
was reduced to 5 mol%. A 25-fold excess of POPC lip-
osomes would theoretically result in a maximal reduction
of the PEG concentration to 0.2 mol%. We estimated
that such a reduction would be sufficient for DNA release
(Fig. 3C). Since the acyl chain length of lipids is known
to exhibit the most prominent effect on monomeric lipid
transfer, we compared the results for SAINT12:0-PEG and
SAINT14:0-PEG. As seen in Fig. 4, the time required to the
onset of DNA release was different for the two derivatives.
Lengthening the alkyl chain by two carbons resulted in a
prolongation of the lag period before the lipoplexes were
able to release their DNA, which occurred over a period
of several hours. In the case of SAINT12:0-PEG (open
squares) the release was completed after 1–2 h, while for
a longer lipid anchor this was accomplished only after 8–10
h (filled squares). The amount of DNA released relative to
the release from PEG-devoid complexes was the same for
both compounds, i.e. 85% of the plasmid DNAwas released
from the PEGylated complexes.
Unsaturation in the acyl chain is another factor affecting
the rate of PEG–lipid migration between membranes. As
shown in Fig. 4, introduction of a double bond shortens the
lag period, preceding DNA release. With the SAINT18:0-
PEG derivative, plasmid accessibility towards picogreen
labeling could not be detected up to incubation periods of
J. Rejman et al. / Biochimica etFig. 6. Intracellular dissociation of SAINT-PEG stabilized lipoplexes.
SAINT-2/DOPE and SAINT-2/DOPE/PEG-lipid liposomes were labeled
with RhPE (red) and complexed with pDNA (green), labeled with Fasttag
nucleic acid labeling kit (Vector Laboratories, Burlingame, CA, USA)
according to the manufacturer’s instructions. Subsequently, the lipoplexes
were added to B16 cells and incubated at 37 jC for 3 h. The samples were
analyzed by confocal microscopy (Leica TCS SP2, Germany). Lipoplexes
were composed of SAINT-2/DOPE/RhPE (49.5:49.5:1); SAINT-2/DOPE/
PEG-lipid/RhPE (45:45:10:1). To distinguish between cell-bound and
internalized lipoplexes, cells were treated with a quencher (trypan blue)
before analysis by confocal microscopy. (a) SAINT-2/DOPE-DNA; 1—
DNA (green), 2—RhPE (red), 3—merged (yellow); (b) SAINT-2/DOPE/
SAINT12:0-PEG-DNA; 1—DNA (green), 2—RhPE (red), 3—merged
(yellow); (c) SAINT-2/DOPE/DSPE-PEG-DNA; 1—DNA (green), 2—
RhPE (red), 3—merged (yellow). Cells transfected with lipoplexes, coated
with exchangeable SAINT12:0-PEG, show a (time-dependent) separation of
lipids and DNA (b). This was not observed for lipoplexes, stabilized with
DSPE-PEG (c).at least 18 h, suggesting its relative immobile behavior, once
inserted into the SAINT-lipoplexes. However, for the un-
saturated derivative (18:1), the process of PEG migration
was essentially completed within 10 h (Fig. 4, open circles).
3.4. Transient stabilization of lipoplexes with SAINT-PEG
enables efficient cellular transfection
After having established the alkyl-chain length and
saturation-dependent release of SAINT-PEG from lipo-
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acceptors, we next investigated how these properties affect-
ed cellular transfection. To this end, B16 cells were trans-
fected with lipoplexes containing different SAINT-PEG
species and DSPE-PEG, and screened for the reporter gene
(GFP) expression 3 days later. For control (i.e. PEG-devoid)
SAINT-2/DOPE lipoplexes, the transfection efficiency
amounted 80% in terms of GFP-positive cells in the
culture. The transfection efficiency for SAINT-PEG deriv-
atives with saturated alkyl chains, which varied from 12
to 16 carbons, was around 60%. No transfection was
observed for the SAINT18:0-PEG derivative and for lip-
oplexes stabilized with DSPE-PEG. Introduction of a double
bond (SAINT18:1-PEG) caused the number of transfected
cells to increase to 70%. Accordingly, these data indicate
that also in association with cellular membranes, SAINT-
PEG derivatives can dissociate from the lipoplexes in a
chain-length- and chain-saturation-dependent manner. To
reveal the time dependence of this process, GFP reporter
gene expression was determined after 1, 2 or 3 days,
following transfection with lipoplexes coated with either
SAINT12:0-PEG or SAINT16:0-PEG. As shown above, in the
presence of anionic liposomes, DNA was released from the
former within 2 h, while in the case of SAINT16:0-PEG, an
incubation of more than 12 h was required for complete
release. As shown in Fig. 5, consistent with a chain-length-
dependent kinetics of SAINT-PEG release, transfection was
readily seen for SAINT12:0-PEG lipoplexes, even after 24 h,
whereas with lipoplexes containing SAINT16:0-PEG, pos-
itive cells (60%) were detected only when the duration of
the experiment had been extended to 3 days.
Finally, a lipid-structure-dependent dissociation of
PEGylated stabilizers from lipoplexes, a prerequisite for
intracellular destabilization of the lipoplexes, causing DNA
release at the endosomal level, could also be visualized byFig. 7. The influence of the charge ratio (+/) on the internalization of lipoplexes,
different charge ratios and their internalization was determined by FACS analysis.
employed as an extracellular fluorescence-quencher. The 100% value represents t
complexes. Vesicles were composed of SAINT-2/DOPE/RhPE (49.5:49.5:1); SAI
stabilized cationic lipids/DNA complexes depends on the net positive charge of pconfocal microscopy. As shown in Fig. 6, compared to cells
transfected with control lipoplexes (A), cells transfected
with complexes coated with exchangeable SAINT12:0-PEG
reveal DNA release from the complex (B), whereas no
dissociation occurs for complexes containing non-exchange-
able DSPE-PEG (C).
3.5. Charge determines internalization of SAINT-PEG
stabilized lipoplexes by cells
Previously, we [5] and others [6,21] reported that the
presence of a DSPE- or Ceramide-based PEG stabilizer
(up to 10%) in lipoplexes does not prevent their asso-
ciation with cells and subsequent internalization. We
observed that also our standard SAINT-PEG-coated com-
plexes (SAINT-2/DOPE/SAINT-PEG, +/ charge ratio
2.5) were efficiently internalized by the cells, even when
further increasing the SAINT-PEG content. Compared to
non-PEGylated complexes, the net uptake of lipoplexes
stabilized with SAINT-PEG, up to 20 mol%, was only
reduced by 20–25%. However, a steric stabilization of
SAINT-PEG, in terms of diminished internalization of
lipoplexes, did become apparent when the charge ratio
was reduced. Fig. 7 presents the data for DSPE-PEG and
SAINT16:0-PEG as constituents of SAINT-2/DOPE/DNA
complexes in which the charge ratio varied from 2.5 to 1.5
(+/ ). At a charge ratio of 2.5, the uptake of PEG-
stabilized complexes was reduced only slightly (~10%)
compared to control, i.e., PEG-devoid lipoplexes. By
contrast, when the net positive charge ratio of the lip-
oplexes was decreased to 1.5, their uptake was reduced by
almost 80% and 60% for DSPE- and SAINT-PEG-con-
taining lipoplexes, respectively. These conditions were
then exploited to investigate whether internalization could
be restored via specific targeting.stabilized with PEG. RhPE labeled vesicles were mixed with pDNA at four
Lipoplexes were incubated with B16 cells for 3 h. Trypan blue (0.04%) was
he fluorescence intensity obtained for non-stabilized SAINT-2/DOPE-DNA
NT-2/DOPE/PEG-lipid/RhPE (45:45:10:1). Note that the internalization of
articles.
Fig. 8. Epithelial glycoprotein 2 targeted delivery mediated by SAINT-2/DOPE lipoplexes stabilized with the SAINT14:0-PEG, analyzed by confocal
microscopy. The EGP-2 expressing B16 melanoma cells (B16.C215) were incubated with antibody (MOC-31)-coupled lipoplexes (SAINT-2/DOPE/
SAINT14:0-PEG-DNA) for 1 h in serum-free medium. Subsequently, the cells were intensely washed with HBSS and further incubated at 37 jC for 0.5 (a), 1
(b), 2 (c), 4 (d) or 12 h (e). To distinguish between cell-bound and internalized lipoplexes, cells presented in panel f were treated with a quencher (trypan blue).
Lipoplexes: SAINT-2/DOPE ratio 1:1; SAINT14:0-PEG 10 mol%; +/ ratio 1.5:1. The lipoplexes remained at the plasma membrane for up to 4 h (a–d),
without being internalized. Images acquired after 12 h (e) of incubation revealed intracellular localization of lipoplexes, as verified by quenching of the
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lipoplexes
To investigate potential targeting of SAINT-PEG stabi-
lized complexes in an in vitro assay, we utilized a cell line
expressing the human epithelial glycoprotein 2 (EGP-2), one
of the best characterized tumor-associated antigens present in
lung carcinoma. Anti-EGP-2 antibody (MOC31) was cou-
pled to MPB-PE-containing lipoplexes by a sulfhydryl-
maleimide coupling technique as described in Section 2.
SAINT14:0-PEG was used as a stabilizer. Cationic lipids and
DNAwere mixed at a charge ratio of 1.5. The cells were first
incubated with antibody-coupled lipoplexes for 1 h. Subse-
quently, they were extensively washed and further cultured
for different periods of time (0.5, 1, 2, 4 or 12 h). The fate of
extracellular fluorescence (f).Table 1
Epithelial glycoprotein 2 targeted delivery mediated by SAINT-2/DOPE lipoplex
24 h 12 h
Ab+ Ab Ab+
Internalization
(fluorescence intensity)
185F 10 11F 5 93F 5
Transfection efficiency
(GFP positive cells; %)
47F 10 0
The EGP-2 expressing B16 melanoma cells (B16.C215) were incubated for 1 h in
DOPE/SAINT14:0-PEG-DNA). Subsequently, the cells were intensely washed wit
between cell-bound and internalized lipoplexes, cells were treated with a que
SAINT14:0-PEG—10 mol%, +/ ratio 1.5:1. Ab+-antibody-coupled lipoplexes
determined for the cells incubated with lipoplexes for 24 h.
For each experiment mean values were obtained from two independent experimethe RhPE labelled lipoplexes was monitored as a function of
time by confocal microscopy and quantified by FACS
analysis. As shown in Fig. 8, the lipoplexes remained at
the plasma membrane for up to 4 h, without being internal-
ized. The initially even distribution of the dye-marked
complexes gradually transformed into a clustered appearance
of complexes. This suggested that the lipoplexes, after initial
random attachment, subsequently migrated and clustered
into specific regions on the plasma membrane. Microscopic
images acquired after 12 h of incubation revealed intracel-
lular localization of lipoplexes, which was confirmed by
applying an extracellular fluorescence quencher, trypan blue
(Fig. 8f ). As quantified by FACS analysis, extending the
incubation time up to 12 h resulted in substantial internali-
zation, which was further increased after 24 h (Table 1).es stabilized with the SAINT14:0-PEG
4 h 1 h
Ab Ab+ Ab Ab+ Ab
10F 2 9F 5 4F 5 5F 5 5F 2
serum-free medium with antibody (MOC31)-coupled lipoplexes (SAINT-2/
h HBSS and further incubated at 37 jC for 1, 4, 12 or 24 h. To distinguish
ncher (trypan blue) and analyzed by FACS. SAINT-2/DOPE ratio 1:1;
; Ab-lipoplexes without coupled antibody. Transfection efficiency was
nts, performed in triplicate.
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PEG-stabilized lipoplexes, regardless of the time of incuba-
tion, indicates that the internalization was antibody-depen-
dent. Additionally, when prior to the incubation with the
targeted lipoplexes, the cells were incubated with free
antibody, lipoplex uptake was strongly reduced. Further-
more, the uptake of antibody-coupled and antibody-free
lipoplexes by the B16 cell line, which does not express
EGP-2, was negligible.
Antibody-coupled lipoplexes were competent to transfect
cells, with an efficiency of around 50% (Table 1).4. Discussion
In this study a novel set of PEGylated lipid analogues has
been synthesized. The PEG-SAINT derivatives display
alkyl-chain length and saturation-dependent exchange prop-
erties. This property provides the possibility for transient
stabilization of lipoplexes, which, moreover, can be specif-
ically targeted to appropriate cellular receptors.
For lipoplexes to be effective in vivo, they require
mutually exclusive properties. They need to be small, stable
and display a prolonged circulation time for appropriate
targeting. However, once internalized, they need to become
destabilized in order to allow DNA delivery. PEG-ceramides
may convey such properties to lipoplexes, but when
employed for stabilization of DODAC/DOPE-DNA com-
plexes, they were reported to strongly inhibit the transfection
efficiency in HepG2 cells [6]. Together with the high costs of
PEG-ceramides synthesis, these considerations prompted us
to search for new PEG-derivatives, combining temporal
stability with good retention of transfection efficiency.
Anchoring the PEG moiety to the cationic lipid SAINT-2
and its insertion into a relative homogenous environment, as
provided by the SAINT-2/DOPE mixture, led to an im-
proved protection of the plasmid (Fig. 2A). Thus, as
revealed by a picogreen assay, in SAINT-2/DOPE/DNA
complexes stabilized with DSPE-PEG and PEG-ceramides,
DNA was (much) less protected (Fig. 2B; Audouy, S. and
Hoekstra, D., unpublished observations). Thus, the structure
of a properly, i.e. transiently, stabilized lipoplex is (co-)
determined by the nature of the anchoring lipid.
Our experimental data show that, contrary to some
other PEG conjugates (e.g. DSPE-PEG), SAINT-PEG
stabilization allows DNA to be released from lipoplexes
in a time-dependent manner. Increasing the hydrophobicity
of the lipid anchor by lengthening the alkyl chain resulted
in a decrease of the rate of DNA release (Fig. 4). As
expected, introduction of a double bond had the opposite
effect (Fig. 4). These dependencies were similar to those
reported for spontaneous dissociation of phospholipids
[22–24] and PEG–lipids [25,26] from vesicles.
The lag period between the addition of PEG acceptor
liposomes and the onset of DNA release together with the
observation that effective DNA release requires reduction ofthe PEG content to 1 mol% suggests that the PEG shield
must be almost entirely removed before DNA release can
occur. The PEG-devoid surface of lipoplexes will permit
close contact between cationic and anionic lipids, thus
allowing lipid transfer between the two systems, thereby
promoting non-bilayer structure formation [27]. Indeed, the
absence of PEG in the lipoplexes is likely to restore the
formation of an inverted hexagonal phase (HII), a feature
which has been proposed to be instrumental in efficient gene
delivery [5,11,28], as it destabilizes the lipoplex structure
and, presumably, the endosomal membrane. Moreover, it
has been reported that PEG–lipids are able to stabilize
lamellar phases in mixtures with DOPE, a phospholipid
preferring the inverted hexagonal phase (HII) [29,30].
Lipoplexes stabilized with DSPE-PEG or long-chain
PEG-ceramides (C14 and C20) are internalized by cells to
similar extents as unstabilized lipoplexes. However, such
complexes display relatively low transfection efficiency
because their stabilization refrains them from interacting
with the endosomal membrane, thus preventing nucleic acid
release and gene expression [5,6]. In the present study we
observed that the number of GFP positive cells transfected
with lipoplexes stabilized with SAINT-PEGs was higher
than 50% for derivatives with alkyl chain lengths of C5:0,
C12:0, C14:0, C16:0 and C18:1. No expression of the
reporter gene occurred for the longest saturated derivative
tested (18:0), presumably due its very slow release, and
hence DNA, from the complex.
The transient SAINT-PEG stabilization was also revealed
by the time-dependent expression of the GFP reporter gene
(Fig. 5). Thus, when using the relatively short SAINT12:0-
PEG derivative, transfected cells were detected already after
24 h, transfection reaching its maximum on the second day.
In case of SAINT16:0-PEG, GFP-positive cells were
detected only after 3 days. A SAINT-PEG chain-length-
and, accordingly, a time-dependent destabilization of the
complex, as reflected by a time-dependent (partial) separa-
tion of lipids and DNA, was also demonstrated by confocal
microscopy (Fig. 6). Note that such redistribution patterns
were not observed for lipoplexes containing DSPE-PEG,
which confirmed earlier studies indicating that such a firm
stabilization inhibits DNA release from lipoplexes, resulting
in its entrapment in the endosomal compartment [5,6].
Therefore, we conclude that SAINT-PEG stabilization is
transient, and allows in a time-dependent manner DNA to
be released from lipoplexes and to escape from the endo-
somal compartment, which results eventually in efficient
transfection. The correlations between alkyl chain length
and unsaturation and exchange rate are very similar to those
reported for the transfer of phospholipids [22,24] and
ceramide-PEGylated derivatives [25,26] between vesicles.
Our data demonstrated that the transfection efficiency of
lipoplexes stabilized with the SAINT-PEG derivatives
(C12:0, C14:0, C16:0, C18:1) was diminished by 10–20%
as compared to control, that is PEG-free SAINT2/DOPE
lipoplexes. This could be explained by the observation that
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released from SAINT-PEG stabilized lipoplexes. As com-
pared to non-stabilized lipoplexes, the maximal release of
DNA from PEGylated complexes was around 85% (Fig. 4).
Evidently, SAINT-PEG does not entirely ‘shield’ the
positive charge of lipoplexes at a charge ratio of 2.5
(+/ ). As a consequence, the SAINT-PEGylated lip-
oplexes still interact with the net negatively charged cell
membranes, resulting in subsequent complex internaliza-
tion. Neither cell association nor subsequent endocytosis
were altered by the polymer. In fact, even an enhanced
association of PEGylated lipoplexes with cells has been
reported, thus arguing against the inertness of distinct
PEGylated lipid analogs [4–6,31,32].
The slight decrease (f 15%) in the internalization of
stabilized SAINT/DOPE lipoplexes (+/ 2.5) could be due
to the fact that the presence of a 5-nm-thick coating might
weaken the electrostatic interactions between complexes and
the plasma membrane. The somewhat stronger effect ob-
served for DSPE-PEG could be attributed to the presence of
the negative charge on its phosphate moiety, which neutral-
izes positive charge of lipoplexes. Our data demonstrated the
transfection efficiency of lipoplexes, the stronger the effect
of PEG, in terms of decreased internalization (Fig. 7).
Since the uptake of SAINT-PEG stabilized lipoplexes
could only be reduced by decreasing the +/ charge ratio
(Fig. 7), we applied these conditions to investigate specific
targeting of our complexes in an in vitro model. Thus, the
internalization of EGP-2-targeted lipoplexes by EGP-2-
transfected cells was antibody dependent, as revealed by
competition experiments, whereas non-targeted lipoplexes
were not taken up by the cells. Both quantitative (FACS)
and qualitative (confocal microscopy) studies revealed a
clear time-dependence of the uptake of the Ab-coupled
lipoplexes. This can be attributed to the slow internalization
of antibody bound to the EGP-2 as reported by Woo et al.
[33]. However, when this antigen was utilized for targeting
adenoviruses, increased luciferase expression was detected
already after 24 h [34]. Our confocal studies also demon-
strated that the initially random and homogeneously distrib-
uted attachment of targeted lipoplexes was subsequently
replaced by a patch-wise appearance. This might imply that
they cluster into certain regions on the plasma membrane
involved in their internalization, as discussed previously in
the context of clathrin-mediated endocytosis, which medi-
ates lipoplex internalization [35]. Moreover, clustering prior
to internalization also matches the mode of internalization
described for polyplexes [36].
In conclusion, in the current work we characterized
lipoplexes stabilized with a novel PEGylated lipid,
SAINT-PEG, in terms of their utility for gene delivery.
Our data demonstrate that stabilization provided by
SAINT-PEG is transient and permits DNA release from
the complex, resulting in expression of the marker gene
(GFP). The structural features of the SAINT lipid acting as
an anchor for the PEG moiety constitute the main determi-nant of the rate of PEG conjugate release. Therefore, a
rational selection may result in the construction of stabilized
lipoplexes with optimal structural features simultaneously
meeting the requirements of retained stability in the vascular
compartment and efficient release of the protective shield
once inside the target cell.Acknowledgements
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